56 results
DEFA14A
RVMD
Revolution Medicines, Inc.
1 Nov 23
Additional proxy soliciting materials
7:15am
; and (xxix) the risk that EQRx’s restructuring or wind-down efforts may negatively impact its business operations and reputation with or ability to serve … negatively impact its business operations and reputation with or ability to serve counterparties or may take longer to realize than expected, as well
425
ewttwq tfv7
1 Nov 23
Business combination disclosure
7:11am
8-K
EX-99.1
gjn6o5i
1 Nov 23
Revolution Medicines Also Announces the Final Exchange Ratio of 0.1112
7:08am
8-K
2vzquhzqf9r
1 Nov 23
Revolution Medicines Also Announces the Final Exchange Ratio of 0.1112
7:08am
425
6p6pyg6tfpa2ya6k0fpg
23 Oct 23
Business combination disclosure
6:13am
DEFM14A
1n2feh
29 Sep 23
Proxy related to merger
4:19pm
424B3
fpeu7ya
29 Sep 23
Prospectus supplement
4:17pm
S-4/A
9jl22yu9z6gtl
27 Sep 23
Registration of securities issued in business combination transactions (amended)
5:25pm
S-4
eso5 iur93ao742
13 Sep 23
Registration of securities issued in business combination transactions
5:20pm
425
4t3dnn3kdf5dzus3hhq
1 Aug 23
Business combination disclosure
5:24pm
425
pjsklir
1 Aug 23
Business combination disclosure
5:22pm
425
nn2clz njv
1 Aug 23
Business combination disclosure
5:16pm
425
cr9rr
1 Aug 23
Business combination disclosure
5:13pm
425
ku8eula0taduv8vugw8
1 Aug 23
Business combination disclosure
5:11pm
425
v638vkwj
1 Aug 23
Business combination disclosure
5:09pm